After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of G1 Therapeutics Inc is $184.79M. A total of 0.73 million shares were traded on the day, compared to an average of 2.02M shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, GTHX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 16 BUYs and 6 SELLs from insiders. Insiders purchased 555,000 shares during that period but sold 65,796.
In the most recent transaction, Malik Rajesh sold 28,600 shares of GTHX for 4.62 per share on Feb 12. After the transaction, the Chief Medical Officer now owns 169,938 company shares. In a previous transaction on Jan 04, Malik Rajesh sold 721 shares at 2.94 per share. GTHX shares that Chief Medical Officer owns now total 169,938.
Among the insiders who sold shares, MURDOCK TERRY L disposed of 721 shares on Jan 04 at a per-share price of $2.94. This resulted in the Chief Operating Officer holding 103,638 shares of GTHX after the transaction. In another insider transaction, Avagliano Mark sold 721 shares at $2.94 per share on Jan 04. Company shares held by the Chief Business Officer now total 117,834.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, GTHX has a high of $5.00 and a low of $1.08.
As of this writing, GTHX has an earnings estimate of -$0.22 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$0.29. The company reported an EPS of -$0.35 in the last quarter, which was -6.10% lower than expectations of -$0.33.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. GTHX’s latest balance sheet shows that the firm has $221.19M in Cash & Short Term Investments as of fiscal 2021. There were $81.94M in debt and $27.61M in liabilities at the time. Its Book Value Per Share was $0.68, while its Total Shareholder’s Equity was $143.54M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GTHX is Buy with a score of 4.00.
